OBJECTIVES: To examine markers of inflammation in 9- and 15-year-olds with high waist circumference and compare these with controls, and to examine the relationships between inflammatory markers and cardiovascular disease (CVD) risk factors. METHODS: Cross-sectional analysis of data from 2 299 Norwegian 9- and 15-year-olds participating in the "Physical activity among Norwegian Children Study". In each sex and age group, the 10 participants with the highest waist circumference (HW) were selected (n=40) for analyses, and a random sample of 40 participants within the same groups were included as controls. Inflammatory markers included C-reactive protein (CRP), leptin, adiponectin, plasminogen activator inhibitor-1 (PAI-1), tumor necrosis factor-alpha (TNF-alpha), hepatocyte growth factor (HGF), resistin and interleukin-6 (IL-6). The CVD risk factors included blood pressure, glucose, insulin, triglycerides and high density lipoprotein cholesterol. RESULTS: HW participants had elevated levels of CRP (mean difference 1.50 mg/l; 95% confidence interval [CI] 0.33 to 2.66), PAI-1 (mean difference 13.3 ng/ml; 95% CI 4.1 to 22.5) and HGF (mean difference 0.29 ng/ml; 95% CI 0.07 to 0.51) compared with controls. All CVD risk factors differed between the HW group and controls. The CVD risk factors were not associated with TNFalpha or IL-6, but CRP, HGF and PAI-1 were related to the metabolic risk score. CONCLUSIONS: Low grade systemic inflammation is already present in youth with high waist circumference. CRP, HGF and PAI-1 may be related to the adverse overall metabolic risk profile observed in these children and adolescents.
OBJECTIVES: To examine markers of inflammation in 9- and 15-year-olds with high waist circumference and compare these with controls, and to examine the relationships between inflammatory markers and cardiovascular disease (CVD) risk factors. METHODS: Cross-sectional analysis of data from 2 299 Norwegian 9- and 15-year-olds participating in the "Physical activity among Norwegian Children Study". In each sex and age group, the 10 participants with the highest waist circumference (HW) were selected (n=40) for analyses, and a random sample of 40 participants within the same groups were included as controls. Inflammatory markers included C-reactive protein (CRP), leptin, adiponectin, plasminogen activator inhibitor-1 (PAI-1), tumor necrosis factor-alpha (TNF-alpha), hepatocyte growth factor (HGF), resistin and interleukin-6 (IL-6). The CVD risk factors included blood pressure, glucose, insulin, triglycerides and high density lipoprotein cholesterol. RESULTS: HW participants had elevated levels of CRP (mean difference 1.50 mg/l; 95% confidence interval [CI] 0.33 to 2.66), PAI-1 (mean difference 13.3 ng/ml; 95% CI 4.1 to 22.5) and HGF (mean difference 0.29 ng/ml; 95% CI 0.07 to 0.51) compared with controls. All CVD risk factors differed between the HW group and controls. The CVD risk factors were not associated with TNFalpha or IL-6, but CRP, HGF and PAI-1 were related to the metabolic risk score. CONCLUSIONS: Low grade systemic inflammation is already present in youth with high waist circumference. CRP, HGF and PAI-1 may be related to the adverse overall metabolic risk profile observed in these children and adolescents.
Authors: Jessica J Chiang; Julienne E Bower; Michael R Irwin; Shelley E Taylor; Andrew J Fuligni Journal: Brain Behav Immun Date: 2017-06-28 Impact factor: 7.217
Authors: Donna Spruijt-Metz; B Adar Emken; Mishala R Spruijt; Joyce M Richey; Laura J Berman; Britni R Belcher; Ya-Wen Hsu; Arianna D McClain; Christianne J Lane; Marc J Weigensberg Journal: Obesity (Silver Spring) Date: 2011-03-24 Impact factor: 5.002
Authors: Fabrício Vasconcellos; André Seabra; Peter T Katzmarzyk; Luiz Guilherme Kraemer-Aguiar; Eliete Bouskela; Paulo Farinatti Journal: Sports Med Date: 2014-08 Impact factor: 11.136
Authors: Melissa L Engel; Christopher L Coe; Brie M Reid; Bonny Donzella; Megan R Gunnar Journal: Psychoneuroendocrinology Date: 2020-11-17 Impact factor: 4.905
Authors: Anna Bugge; Bianca El-Naaman; Robert G McMurray; Karsten Froberg; Claus Henrik Nielsen; Klaus Müller; Lars Bo Andersen Journal: Exp Diabetes Res Date: 2012-01-05